Correction: Invitrogen Suit Against GE Healthcare Transferred to Texas | GenomeWeb

Correction: This article has been corrected to relect that this is not a new suit, but rather a lawsuit that is a couple of years old that was transferred from Maryland to Texas. Court documents did not disclose that the suit was transferred, but rather was listed as a new filing.

NEW YORK (GenomeWeb News) – A lawsuit that Invitrogen, a division of Life Technologies, filed against GE Healthcare a couple of years ago alleging infringement of several patents held by Invitrogen has been transferred to a Texas court from Maryland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.